V. Segarra et al., DEGRADATION PROFILE AND IDENTIFICATION OF THE MAJOR DEGRADATION PRODUCTS OF DOBUPRIDE UNDER SEVERAL CONDITIONS BY GC MS AND HPLC-PARTICLE BEAM MS/, Journal of pharmaceutical and biomedical analysis, 13(8), 1995, pp. 987-993
The effect of pH, light, temperature and oxygen on the stability of do
bupride (1), a novel gastroprokinetic drug, has been studied, storing
the sample in the solid state and as a solution in methanol-water. The
main forced degradation products have been identified by means of tec
hniques such as GC/MS and HPLC-particle beam/MS, and two major degrada
tion pathways have been characterized. One degradation route involves
the loss of chlorine, yielding [1-(1,3-dioxolan-2-ylmethyl)piperid-4-y
l]benzamide (4) as the major degradation product. The second pathway r
esults from cleavage of the piperidine-amide bond, producing 4-amino-2
-butoxy-5-chlorobenzamide (2) as the major degradation product. Under
the studied conditions, except when exposed to direct light in solutio
n, dobupride has been shown to be very stable: after 5 months storage,
the benzamide 2 (second pathway) was the only product identified (les
s than 0.5%). However, when dobupride in solution is exposed to natura
l or artificial sunlight, degradation is very fast, and after 7 days o
nly 5% of the unchanged product remains. Under these circumstances, th
e main degradation route is the first one, with compound 4 being the m
ost abundant degradation product, and compound 2 only being detectable
in small amounts.